Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non-pregnant Women 18-40 Years of Age.

Clinical trial NCT02459262 · COMPLETED

Trial details

NCT number: NCT02459262
Sponsor: Minervax ApS
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infection by Streptococcus Group B

Start date: 2015-05-01
Primary completion: 2017-04-12
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.